Vimarsana
Biggest News Aggregation in the World

Rapid Mobile Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rapid Mobile Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rapid Mobile Test Today - Breaking & Trending Today

Canary's 25-Second, 98% Sensitivity, Digital COVID-19 Saliva Test [...] | Comunicati stampa CataniaOggi - Vimarsana News

Canary's 25-Second, 98% Sensitivity, Digital COVID-19 Saliva Test [...] | Comunicati stampa CataniaOggi

15 marzo 2021 08:04 Fonte: Adnkronos #salute-e-benessere - Non-invasive ultra-rapid test delivers 98% sensitivity and 100% specificity in symptomatic and asymptomatic individuals with SARS-CoV-2 including variants - Designed for point-of-care (POC) diagnosis, ease of use and rapid mass-screening, the digital platform enables efficient track & trace and has potential to open up the economy NEW YORK, March 15, 2021 /PRNewswire/ -- Med tech company Pelican Diagnostics, a Canary Global Inc. company has received CE Mark for a 25-second COVID-19 saliva test, delivering real-time results with 98%...

Canary's 25-Second, 98% Sensitivity, Digital COVID-19 Saliva Test Achieves CE Mark - Vimarsana News

Canary's 25-Second, 98% Sensitivity, Digital COVID-19 Saliva Test Achieves CE Mark

Share this article Share this article NEW YORK, March 15, 2021 /PRNewswire/ -- Med tech company Pelican Diagnostics, a Canary Global Inc. company has received CE Mark for a 25-second COVID-19 saliva test, delivering real-time results with 98% sensitivity and 100% specificity. The Pelican COVID-19 Ultra-Rapid Mobile Test for the detection of SARS-CoV-2 is now cleared for sale and distribution in the European Union (EU). The test is also under review at the U.S. Food and Drug Administration (FDA) under Emergency Use Authorization (EUA) for Over-the-Counter (OTC), non-prescription use and as a s...

Canary Health Technologies Submits a Revolutionary 25-Second, 98% Sensitivity, Digital COVID-19 Saliva Test to the FDA - Vimarsana News

Canary Health Technologies Submits a Revolutionary 25-Second, 98% Sensitivity, Digital COVID-19 Saliva Test to the FDA

/PRNewswire/ -- Med tech company Canary Health Technologies, Inc. has developed a 25-second COVID-19 test, delivering real-time results with 98% sensitivity...